Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Tumor mutational burden as a determinant of metastatic dissemination patterns.

Molecular oncology·2026
Same author

High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models.

Nature communications·2025
Same author

Identifying the key components of a diet and lifestyle screener for people living with and beyond cancer: an e-Delphi study.

BMJ open·2025
Same author

Diagnostic and Prognostic Value of Angiogenic Status in Hereditary Hemorrhagic Telangiectasia.

Diagnostics (Basel, Switzerland)·2025

Related Experiment Video

Updated: Nov 26, 2025

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

11.2K

dPCR application in liquid biopsies: divide and conquer.

Andrea Moreno-Manuel1,2, Silvia Calabuig-Fariñas1,2,3,4, Antonia Obrador-Hevia5,6

  • 1Molecular Oncology Laboratory, Fundación Para La Investigación del Hospital General Universitario De Valencia, Valencia, Spain.

Expert Review of Molecular Diagnostics
|December 11, 2020
PubMed
Summary
This summary is machine-generated.

Digital PCR (dPCR) offers high sensitivity for liquid biopsy (LB) in oncology, enabling precise cancer genomic profiling. While effective, further improvements in multiplexing and standardization are needed for optimal clinical application.

Keywords:
Digital PCRbiomarkercfDNActDNAliquid biopsyoncology.precision medicine

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.0K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.1K

Related Experiment Videos

Last Updated: Nov 26, 2025

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

11.2K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.0K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Precision medicine in oncology relies on biomarker-driven therapies and minimally invasive liquid biopsy (LB) for cancer genomic profiling.
  • Liquid biopsy analyzes circulating tumor DNA (ctDNA), but requires highly sensitive detection technologies.
  • Digital PCR (dPCR) is a powerful tool for absolute and accurate quantification of target molecules, addressing the sensitivity challenge.

Purpose of the Study:

  • To review the fundamentals and common approaches of digital PCR (dPCR).
  • To discuss the advantages and limitations of dPCR in the context of liquid biopsy (LB) in oncology.
  • To provide expert opinion on the role of dPCR in current and future cancer diagnostics.

Main Methods:

  • Review of digital PCR (dPCR) principles and quantification strategies.
  • Discussion of sample partitioning techniques in dPCR.
  • Analysis of dPCR performance metrics for liquid biopsy applications.

Main Results:

  • Digital PCR (dPCR) is a highly sensitive method for liquid biopsy (LB) analysis in oncology.
  • dPCR enables absolute and accurate quantification of circulating tumor DNA (ctDNA).
  • Limitations include challenges in multiplexing and protocol standardization.

Conclusions:

  • dPCR is a valuable tool for sensitive LB analysis in oncology.
  • Further improvements in dPCR technology are necessary for broader clinical adoption.
  • dPCR serves as a complementary technique to next-generation sequencing (NGS) for treatment monitoring and minimal residual disease assessment.